Researchers reveal how allergens may trigger itching
Certain sensory neurons and Substance P are potential drug targets for the development of novel allergy preventions or treatments, according to scientists.
In a new study, scientists have shown that when certain neurons in the skin detect allergens, they release a neuropeptide called Substance P, which is essential to the development of an allergen-induced immune response. According to the team, the finding could lead to the development of more effective novel allergy prevention and treatment strategies.
The researchers stated that while the immune response to pathogens is well understood, how allergens such as pollen, dust mites or animal fur are detected is not. In particular, the steps from exposure to an allergen to the development of itching were unknown.
“The focus has been on dendritic cells and T cells, which play a major role both in allergies and in protecting the body from pathogens, such as viruses, bacteria or fungi. Now we know that sensory nerves link allergen exposure to immune activation,” said Dr Caroline Sokol, investigator at Massachusetts General Hospital (MGH)’s Center for Immunology and Inflammatory Diseases, US, and lead author of the study in Immunity.
Sokol explained: “Allergy-triggering dendritic cells are located next to allergen-responsive neurons in the skin. We found that when exposed to an allergen, these neurons release Substance P which then directly induces migration of those dendritic cells to the lymph nodes, where they, in turn, activate T cells. Those T cells then marshal the attack against the allergen invader.” The allergic-response triggering dendritic cells are called CD301b+ DCs.
In their study, Sokol said the team studied this chain of events in both cultured dendritic cells and living systems and identified that something different was happening in the living systems, compared to the isolated cells. “So we hypothesised that in living systems there must be some intermediate step between exposure to the allergen and activation of the dendritic cells,” said Sokol.
Their tests support this hypothesis: first, they demonstrated that sensory neurons detect allergens both in isolated cells and in mice; then they showed that CD301b+ dendritic cells can be found close to sensory neurons in the skin. According to the team, when pulled together these two findings suggested that sensory neurons play a major role in immune cell activation in response to allergens.
Further studies demonstrated that by chemically blocking allergy-sensing neurons in mice, the researchers could interrupt the activation of an allergic response. They also showed that Substance P is released by allergen-activated neurons in both cultured cells and living systems and that Substance P, on its own, can activate the specific types of dendritic cells needed to in turn activate the T cells and complete the allergic response. Further, they showed that blocking sensory neuron function inhibited the activation of T cells associated with the allergic response.
Sokol concluded that because the sensory-neuron-dependent pathway and Substance P are necessary to trigger an immune response to allergens, interrupting them using novel therapeutics could enable us to control or stop the allergic immune response in future.